PATENT CLAIM ANALYSIS

Application Number: 16027967
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "179100"]

Abstract:
Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.

Claim (Index 19):
The immunoconjugate of  claim 16 , wherein the heavy chain variable domain (V H ) and light chain variable domain (V L ) of the antibody comprise the amino acid sequences of:\n a) SEQ ID NOs: 5 and 6, respectively; b) SEQ ID NOs: 5 and 50, respectively; c) SEQ ID NOs: 48 and 6, respectively; or d) SEQ ID NOs: 48 and 50, respectively.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11978122', '14517682', '12939533', '13796768', '15130667']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972381838299798
- 35 USC 102 Novelty (BERT): 0.5473433948581118
- Combined Prediction Score: 0.7722487049327931
- Mean Citation Score: 384.160708
- Max Citation Score: 410.674
- Similarity Product: 307.2911072968245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test